Enhanced CD4+cellular apoptosis by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with progressive HIV-1 infection

被引:17
|
作者
Wade, Jessica [1 ,2 ]
Sterjovski, Jasminka [1 ,3 ]
Gray, Lachlan [1 ,2 ]
Roche, Ichael [1 ,3 ]
Chiavaroli, Lisa [1 ]
Ellett, Anne [1 ]
Jakobsen, Martin R. [1 ]
Cowley, Daniel [1 ,3 ]
Pereira, Candida da Fonseca [1 ]
Saksena, Nitin [4 ]
Wang, Bin [4 ]
Purcell, Damian F. J. [2 ]
Karlsson, Ingrid [5 ]
Fenyoe, Eva-Maria [5 ]
Churchill, Melissa [1 ,3 ]
Gorry, Paul R. [1 ,2 ,3 ]
机构
[1] Burnet Inst, Ctr Virol, Melbourne, Vic 3001, Australia
[2] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia
[3] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia
[4] Westmead Millennium Inst, Westmead, NSW, Australia
[5] Lund Univ, Lund, Sweden
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
HIV-1; Env; CD4; CCR5; Apoptosis; Active caspase-3; HUMAN-IMMUNODEFICIENCY-VIRUS; MT-2 CELL TROPISM; CD4; T-CELLS; CORECEPTOR USAGE; ACQUIRED-IMMUNODEFICIENCY; BYSTANDER APOPTOSIS; DISEASE PROGRESSION; LYMPHOCYTE DEPLETION; CHEMOKINE RECEPTORS; FUNCTIONAL-ANALYSIS;
D O I
10.1016/j.virol.2009.10.029
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
CCR5-using (R5) human immunodeficiency virus type 1 (HIV-1) strains cause CD4+ T-cell loss in most infected individuals, but mechanisms underlying cytopathicity of R5 viruses are poorly understood. We investigated mechanisms contributing to R5 envelope glycoprotein (Env)-mediated cellular apoptosis by constructing a panel of retroviral vectors engineered to co-express GFP and R5 Envs derived from two HIV-1 infected subjects spanning asymptomatic (Early, E-R5 Envs) to late stages of infection (Late, L-R5 Envs). The L-R5 Envs induced significantly more cellular apoptosis than E-R5 Envs, but only in Env-expressing (GFP-positive) cells, and only in cells where CD4 and CCR5 levels were limiting. Studies with fusion-defective Env mutants showed induction of apoptosis required membrane-fusing events. Our results provide evidence for an intracellular mechanism of R5 Env-induced apoptosis of CD4+ cells that requires membrane fusion. Furthermore, they contribute to a better understanding of mechanisms involved in CD4+ T-cell loss in subjects experiencing progressive R5 HIV-1 infection. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:246 / 255
页数:10
相关论文
共 50 条
  • [21] A Tyrosine-Sulfated CCR5-Mimetic Peptide Promotes Conformational Transitions in the HIV-1 Envelope Glycoprotein
    Kwong, Jo Ann
    Dorfman, Tatyana
    Quinlan, Brian D.
    Chiang, Jessica J.
    Ahmed, Asim A.
    Choe, Hyeryun
    Farzan, Michael
    JOURNAL OF VIROLOGY, 2011, 85 (15) : 7563 - 7571
  • [22] CD4-binding site alterations in CCR5-using HIV-1 envelopes influencing gp120-CD4 interactions and fusogenicity
    Sterjovski, Jasminka
    Churchill, Melissa J.
    Roche, Michael
    Ellett, Anne
    Farrugia, William
    Wesselingh, Steven L.
    Cunningham, Anthony L.
    Ramsland, Paul A.
    Gorry, Paul R.
    VIROLOGY, 2011, 410 (02) : 418 - 428
  • [23] Allosteric regulation of CCR5 by guanine nucleotides and HIV-1 envelope
    Staudinger, R
    Wang, XH
    Bandrés, JC
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 286 (01) : 41 - 47
  • [24] Macrophage-tropic HIV-1 variants from brain demonstrate alterations in the way gp120 engages both CD4 and CCR5
    Salimi, Hamid
    Roche, Michael
    Webb, Nicholas
    Gray, Lachlan R.
    Chikere, Kelechi
    Sterjovski, Jasminka
    Ellett, Anne
    Wesselingh, Steve L.
    Ramsland, Paul A.
    Lee, Benhur
    Churchill, Melissa J.
    Gorry, Paul R.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2013, 93 (01) : 113 - 126
  • [25] Identification of HIV-1 Envelope Mutations that Enhance Entry Using Macaque CD4 and CCR5
    Roop, Jeremy, I
    Cassidy, Noah A.
    Dingens, Adam S.
    Bloom, Jesse D.
    Overbaugh, Julie
    VIRUSES-BASEL, 2020, 12 (02):
  • [26] Protective effect of CCR5 Δ32 heterozygosity is restricted by SDF-1 genotype in children with HIV-1 infection
    Sei, S
    Boler, AM
    Nguyen, GT
    Stewart, SK
    Yang, QE
    Edgerly, M
    Wood, LV
    Brouwers, P
    Venzon, DJ
    AIDS, 2001, 15 (11) : 1343 - 1352
  • [27] Targeting CCR5 trafficking to inhibit HIV-1 infection
    Boncompain, Gaelle
    Herit, Floriane
    Tessier, Sarah
    Lescure, Aurianne
    Del Nery, Elaine
    Gestraud, Pierre
    Staropoli, Isabelle
    Fukata, Yuko
    Fukata, Masaki
    Brelot, Anne
    Niedergang, Florence
    Perez, Franck
    SCIENCE ADVANCES, 2019, 5 (10):
  • [28] Maraviroc - a CCR5 antagonist for the treatment of HIV-1 infection
    Van Der Ryst, Elna
    FRONTIERS IN IMMUNOLOGY, 2015, 6
  • [29] CD4 MODULATION OF NONINFECTED HUMAN T-LYMPHOCYTES BY HIV-1 ENVELOPE GLYCOPROTEIN GP120 - CONTRIBUTION TO THE IMMUNOSUPPRESSION SEEN IN HIV-1 INFECTION BY INDUCTION OF CD4 AND CD3 UNRESPONSIVENESS
    THEODORE, AC
    KORNFELD, H
    WALLACE, RP
    CRUIKSHANK, WW
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1994, 7 (09): : 899 - 907
  • [30] Syncytial apoptosis signaling network induced by the HIV-1 envelope glycoprotein complex: an overview
    Nardacci, R.
    Perfettini, J-L
    Grieco, L.
    Thieffry, D.
    Kroemer, G.
    Piacentini, M.
    CELL DEATH & DISEASE, 2015, 6 : e1846 - e1846